The DOI matches its Crossref record; 65 of the 66 references it cites were found in a registry or an index.
Assessment of Glutamate Transporter GLAST (EAAT1)-Deficient Mice for Phenotypes Relevant to the Negative and Executive/Cognitive Symptoms of Schizophrenia
Open accessAbstract
Glutamatergic dysfunction is increasingly implicated in the pathophysiology of schizophrenia. Current models postulate that dysfunction of glutamate and its receptors underlie many of the symptoms in this disease. However, the mechanisms involved are not well understood. Although elucidating the role for glutamate transporters in the disease has been limited by the absence of pharmacological tools that selectively target the transporter, we recently showed that glial glutamate and aspartate transporter (GLAST; excitatory amino-acid transporter 1) mutant mice exhibit abnormalities on behavioral measures thought to model the positive symptoms of schizophrenia, some of which were rescued by treatment with either haloperidol or the mGlu2/3 agonist, LY379268 the mGlu2/3 agonist, LY379268. To further determine the role of GLAST in schizophrenia-related behaviors we tested GLAST mutant mice on a series of behavioral paradigms associated with the negative (social withdrawal, anhedonia), sensorimotor gating (prepulse inhibition of startle), and executive/cognitive (discrimination learning, extinction) symptoms of schizophrenia. GLAST knockout (KO) mice showed poor nesting behavior and abnormal sociability, whereas KO and heterozygous (HET) both demonstrated lesser preference for a novel social stimulus compared to wild-type littermate controls. GLAST KO, but not HET, had a significantly reduced acoustic startle response, but no significant deficit in prepulse inhibition of startle. GLAST KO and HET showed normal sucrose preference. In an instrumental visual discrimination task, KO showed impaired learning. By contrast, acquisition and extinction of a simple instrumental response was normal. The mGlu2/3 agonist, LY379268, failed to rescue the discrimination impairment in KO mice. These findings demonstrate that gene deletion of GLAST produces select phenotypic abnormalities related to the negative and cognitive symptoms of schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Alterations in astrocytic glutamate clearance are known to occur in schizophrenia and other psychiatric illnesses, and mice with glutamate/aspartate transporter (GLAST) deletion show phenotypic abnormalities such as mental and behavioral deficits. 90 , 91”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [90]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glutamate neurotoxicity and diseases of the nervous system
Choi, D. W. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 8,188
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
PHARMACOLOGY AND FUNCTIONS OF METABOTROPIC GLUTAMATE RECEPTORS
Conn, P. J., & Pin, J. (1997) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.37.1.205 · Cited by 3,083
Rothstein, J. D., Dykes-Hoberg, M., Pardo, C. A., Bristol, L. A., Jin, L., Kuncl, R. W., Kanai, Y., Hediger, M. A., Wang, Y., Schielke, J. P., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80086-0 · Cited by 2,534
Krishnan, V., Han, M.-H., Graham, D. L., Berton, O., Renthal, W., Russo, S. J., LaPlant, Q., Graham, A., Lutter, M., Lagace, D. C., et al. (2007) · Cell · doi:10.1016/j.cell.2007.09.018 · Cited by 2,307 · cited 1×
“Anhedonia was measured by preference for a sucrose solution over water, using a two-bottle free choice method as previously described (Bechtholt et al, 2008; Krishnan et al, 2007).”
MethodSchizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
Rare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia
Walsh, T., McClellan, J. M., McCarthy, S. E., Addington, A. M., Pierce, S. B., Cooper, G. M., Nord, A. S., Kusenda, M., Malhotra, D., Bhandari, A., et al. (2008) · Science · doi:10.1126/science.1155174 · Cited by 1,800
Glutamate receptor dysfunction and schizophrenia
Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240016004 · Cited by 1,685
The neuropathology of schizophrenia
Harrison, P. J. (1999) · Brain · doi:10.1093/brain/122.4.593 · Cited by 1,677
Homayoun, H., & Moghaddam, B. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2213-07.2007 · Cited by 1,231
Flagged first, then by citations
1 of the 66 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- American Psychiatric Association (APA) (2000). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. (text rev.), American Psychiatric Press: Washington, DC.
Cited by
Sorted by citations
The neurobiology of anhedonia and other reward-related deficits
Der-Avakian, A., & Markou, A. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.11.005 · Cited by 1,130
Major depressive disorder: hypothesis, mechanism, prevention and treatment
Cui, L., Li, S., Wang, S., Wu, X., Liu, Y., Yu, W., Wang, Y., Tang, Y., Xia, M., & Li, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01738-y · Cited by 1,244
“90,91 Adenosine triphosphate (ATP) .”
Glutamate as a neurotransmitter in the healthy brain
Zhou, Y., & Danbolt, N. C. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1180-8 · Cited by 1,056
The neural basis of reversal learning: An updated perspective
Izquierdo, A., Brigman, J. L., Radke, A. K., Rudebeck, P. H., & Holmes, A. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2016.03.021 · Cited by 670
Self-citationAstrocytes in human central nervous system diseases: a frontier for new therapies
Verkhratsky, A., Butt, A., Li, B., Illes, P., Zorec, R., Semyanov, A., Tang, Y., & Sofroniew, M. V. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01628-9 · Cited by 428
The touchscreen operant platform for testing learning and memory in rats and mice
Horner, A. E., Heath, C. J., Hvoslef‐Eide, M., Kent, B. A., Kim, C. H., Nilsson, S. R. O., Alsiö, J., Oomen, C. A., Holmes, A., Saksida, L. M., et al. (2013) · Nature Protocols · doi:10.1038/nprot.2013.122 · Cited by 412
Self-citationGABA and Glutamate Transporters in Brain
Zhou, Y., & Danbolt, N. C. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00165 · Cited by 361
van den Buuse, M. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp132 · Cited by 352
Influence of glutamate and GABA transport on brain excitatory/inhibitory balance
Sears, S. M. S., & Hewett, S. J. (2021) · Experimental Biology and Medicine · doi:10.1177/1535370221989263 · Cited by 371
The SLC1 high-affinity glutamate and neutral amino acid transporter family
Kanai, Y., Clémençon, B., Simonin, A., Leuenberger, M., Lochner, M., Weisstanner, M., & Hediger, M. A. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2013.01.001 · Cited by 329
Bussey, T. J., Holmes, A., Lyon, L., Mar, A. C., McAllister, K. A. L., Nithianantharajah, J., Oomen, C. A., & Saksida, L. M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.04.011 · Cited by 299
Self-citationThe touchscreen operant platform for assessing executive function in rats and mice
Mar, A. C., Horner, A. E., Nilsson, S. R. O., Alsiö, J., Kent, B. A., Kim, C. H., Holmes, A., Saksida, L. M., & Bussey, T. J. (2013) · Nature Protocols · doi:10.1038/nprot.2013.123 · Cited by 271
Self-citationA Role for p53 in the Adaptation to Glutamine Starvation through the Expression of SLC1A3
Tajan, M., Hock, A. K., Blagih, J., Robertson, N. A., Labuschagne, C. F., Kruiswijk, F., Humpton, T. J., Adams, P. D., & Vousden, K. H. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.07.005 · Cited by 230
Cognitive remediation for negative symptoms of schizophrenia: A network meta-analysis
Cella, M., Preti, A., Edwards, C., Dow, T., & Wykes, T. (2017) · Clinical Psychology Review · doi:10.1016/j.cpr.2016.11.009 · Cited by 215
Chronic alcohol produces neuroadaptations to prime dorsal striatal learning
DePoy, L. M., Daut, R. A., Brigman, J. L., MacPherson, K. P., Crowley, N. A., Gunduz‐Cinar, O., Pickens, C. L., Çınar, R., Saksida, L. M., Kunos, G., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308198110 · Cited by 204
Self-citationSerine racemase is associated with schizophrenia susceptibility in humans and in a mouse model
Labrie, V., Fukumura, R., Rastogi, A., Fick, L. J., Wang, W., Boutros, P. C., Kennedy, J. L., Semeralul, M. O., Lee, F. H., Baker, G. B., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp261 · Cited by 193
Brigman, J. L., Mathur, P., Harvey-White, J., Izquierdo, A., Saksida, L. M., Bussey, T. J., Fox, S., Deneris, E., Murphy, D. L., & Holmes, A. (2010) · Cerebral Cortex · doi:10.1093/cercor/bhp266 · Cited by 184
Self-citationExcitatory Amino Acid Transporters in Physiology and Disorders of the Central Nervous System
Malik, A. R., & Willnow, T. E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225671 · Cited by 170
Paradoxical reversal learning enhancement by stress or prefrontal cortical damage: rescue with BDNF
Graybeal, C., Feyder, M. J., Schulman, E., Saksida, L. M., Bussey, T. J., Brigman, J. L., & Holmes, A. (2011) · Nature Neuroscience · doi:10.1038/nn.2954 · Cited by 166
Self-citationGluN2B in corticostriatal circuits governs choice learning and choice shifting
Brigman, J. L., Daut, R. A., Wright, T., Gunduz‐Cinar, O., Graybeal, C., Davis, M. I., Jiang, Z., Saksida, L. M., Jinde, S., Pease, M. W., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3457 · Cited by 162
Self-citationGlutamate signaling in the pathophysiology and therapy of schizophrenia
Lin, C., Lane, H., & Tsai, G. E. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.03.023 · Cited by 154
Aida, T., Yoshida, J., Nomura, M., Tanimura, A., Iino, Y., Soma, M., Bai, N., Ito, Y., Cui, W., Aizawa, H., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.26 · Cited by 151
Self-citationPál, B. Z. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2837-5 · Cited by 140
Bauer, D., Haroutunian, V. H., Meador‐Woodruff, J. H., & McCullumsmith, R. E. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.07.025 · Cited by 124
Genetic Models of Sensorimotor Gating: Relevance to Neuropsychiatric Disorders
Powell, S. B., Weber, M., & Geyer, M. A. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2011_195 · Cited by 127
Disturbed Neurotransmitter Transporter Expression in Alzheimer’s Disease Brain
Chen, K. H., Reese, E. A., Kim, H., Rapoport, S. I., & Rao, J. S. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110002 · Cited by 122
RetractedReversal learning and attentional set-shifting in mice
Bissonette, G. B., & Powell, E. M. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.03.011 · Cited by 121
Automated test of behavioral flexibility in mice using a behavioral sequencing task in IntelliCage
Endo, T., Maekawa, F., Võikar, V., Haijima, A., Uemura, Y., Zhang, Y., Miyazaki, W., Suyama, S., Shimazaki, K., Wolfer, D. P., et al. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.02.037 · Cited by 119
Grewer, C. T., Gameiro, A. M., & Rauen, T. (2013) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-013-1397-7 · Cited by 115
Translational potential of astrocytes in brain disorders
Verkhratsky, A., Steardo, L., Parpura, V., & Montana, V. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.003 · Cited by 115
Martin, C., Houitte, D., Guillermier, M., Petit, F., Bonvento, G., & Gurden, H. (2012) · Frontiers in Neural Circuits · doi:10.3389/fncir.2012.00001 · Cited by 106
Mouse models of genetic effects on cognition: Relevance to schizophrenia
Papaleo, F., Lipska, B. K., & Weinberger, D. R. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.04.025 · Cited by 107
Disentangling the Role of Astrocytes in Alcohol Use Disorder
Adermark, L., & Bowers, M. S. (2016) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13168 · Cited by 108
The Glutamate–Glutamine Cycle in Epilepsy
Eid, T., Gruenbaum, S. E., Dhaher, R., Lee, T.-S. W., Zhou, Y., & Danbolt, N. C. (2016) · Advances in neurobiology · doi:10.1007/978-3-319-45096-4_14 · Cited by 99
Gene expression deficits in pontine locus coeruleus astrocytes in men with major depressive disorder
Chandley, M., Szebeni, K., Szebeni, A., Crawford, J. D., Stockmeier, C. A., Turecki, G., Miguel-Hidalgo, J. J., & Ordway, G. A. (2013) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.120110 · Cited by 101
Gaisler-Salomon, I., Miller, G. M., Chuhma, N., Lee, S., Zhang, H., Ghoddoussi, F., Lewandowski, N., Fairhurst, S., Wang, Y., Conjard-Duplany, A., et al. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.58 · Cited by 86
Brigman, J. L. (2009) · Frontiers in Behavioral Neuroscience · doi:10.3389/neuro.08.002.2009 · Cited by 85
Barkus, C., Feyder, M. J., Graybeal, C., Wright, T., Wiedholz, L. M., Izquierdo, A., Kiselycznyk, C., Schmitt, W. B., Sanderson, D. J., Rawlins, J. N. P., et al. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.06.005 · Cited by 82
Self-citationNotter, T. (2021) · Brain and Neuroscience Advances · doi:10.1177/23982128211009148 · Cited by 75
Pumilio-2 Function in the Mouse Nervous System
Siemen, H., Colas, D., Heller, H. C., Brüstle, O., & Pera, R. A. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025932 · Cited by 76
Transport of Amino Acids in the Kidney
Makrides, V., Camargo, S. M. R., & Verrey, F. (2014) · Comprehensive physiology · doi:10.1002/cphy.c130028 · Cited by 79
Hayashi, M. K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041177 · Cited by 76
Eack, S. M., Mesholam‐Gately, R. I., Greenwald, D. P., Hogarty, S. S., & Keshavan, M. S. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.03.020 · Cited by 72
Bartko, S. J., Romberg, C., White, B., Wess, J., Bussey, T. J., & Saksida, L. M. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.023 · Cited by 71
Self-citationMutant Mouse Models: Genotype-Phenotype Relationships to Negative Symptoms in Schizophrenia
O’Tuathaigh, C. M. P., Kirby, B. P., Moran, P. M., & Waddington, J. L. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp125 · Cited by 73
Shan, D., Lucas, E. K., Drummond, J. B., Haroutunian, V. H., Meador‐Woodruff, J. H., & McCullumsmith, R. E. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2012.12.019 · Cited by 68
Kolisnyk, B., Al‐Onaizi, M., Hirata, P. H. F., Guzmán, M. S., Nikolova, S., Barbash, S., Soreq, H., Bartha, R., Prado, M. A. M., & Prado, V. F. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1933-13.2013 · Cited by 70
Strains and Stressors: An Analysis of Touchscreen Learning in Genetically Diverse Mouse Strains
Graybeal, C., Bachu, M., Mozhui, K., Saksida, L. M., Bussey, T. J., Sagalyn, E., Williams, R. W., & Holmes, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087745 · Cited by 66
Self-citationAstrocytic Regulation of Glutamate Transmission in Schizophrenia
Mei, Y.-Y., Wu, D., & Zhou, N. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00544 · Cited by 67
Control of Long-Term Plasticity by Glutamate Transporters
Valtcheva, S., & Venance, L. (2019) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2019.00010 · Cited by 64
RETRACTED: SLC1A3 promotes gastric cancer progression via the PI3K/AKT signalling pathway
Xu, L., Chen, J., Jia, L., Chen, X., Moumin, F. A., & Cai, J. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16060 · Cited by 62
RetractedWhole transcriptome RNA-Seq allelic expression in human brain
Smith, R. M., Webb, A., Papp, A. C., Newman, L. C., Handelman, S. K., Suhy, A., Mascarenhas, R., Oberdick, J., & Sadée, W. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-571 · Cited by 67
General Pathophysiology of Astroglia
Verkhratsky, A., Ho, M. S., Vardjan, N., Zorec, R., & Parpura, V. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-13-9913-8_7 · Cited by 66
Mice mutant for genes associated with schizophrenia: Common phenotype or distinct endophenotypes?
Desbonnet, L., Waddington, J. L., & O’Tuathaigh, C. M. P. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.04.001 · Cited by 57
Uncoupling N-acetylaspartate from brain pathology: implications for Canavan disease gene therapy
von Jonquières, G., Spencer, Z. H. T., Rowlands, B. D., Klugmann, C. B., Bongers, A., Harasta, A. E., Parley, K. E., Cederholm, J. M. E., Teahan, O., Pickford, R., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1784-9 · Cited by 58
McCullumsmith, R. E., O'Donovan, S. M., Drummond, J. B., Benesh, F., Simmons, M. S., Roberts, R. C., Lauriat, T. L., Haroutunian, V. H., & Meador‐Woodruff, J. H. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.148 · Cited by 57
Molecular approaches for manipulating astrocytic signaling in vivo
Xie, A. X., Petravicz, J., & McCarthy, K. D. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00144 · Cited by 61
Predictably irrational: assaying cognitive inflexibility in mouse models of schizophrenia
Brigman, J. L. (2010) · Frontiers in Neuroscience · doi:10.3389/neuro.01.013.2010 · Cited by 52
Behavioral Tasks Evaluating Schizophrenia-like Symptoms in Animal Models: A Recent Update
Ang, M. J., Lee, S., Kim, J.-C., Kim, S., & Moon, C. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200814175114 · Cited by 52
Bhat, S., El‐Kasaby, A., Freissmuth, M., & Sučić, S. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107785 · Cited by 53
Adermark, L., Lagström, O., Loftén, A., Licheri, V., Havenäng, A., Loi, E. A., Stomberg, R., Söderpalm, B., Domi, A., & Ericson, M. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-021-01232-x · Cited by 51
Young, J. W., & Markou, A. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv093 · Cited by 51
Pedersen, C. S., Sørensen, D. B., Parachikova, A. I., & Plath, N. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.023 · Cited by 50
Shan, D., Mount, D., Moore, S., Haroutunian, V. H., Meador‐Woodruff, J. H., & McCullumsmith, R. E. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.01.028 · Cited by 50
Iasevoli, F., Tomasetti, C., Marmo, F., Bravi, D., Arnt, J., & de Bartolomeis, A. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1954-0 · Cited by 49
Lederle, L. I., Weber, S. C., Wright, T., Feyder, M. J., Brigman, J. L., Crombag, H. S., Saksida, L. M., Bussey, T. J., & Holmes, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015536 · Cited by 50
Self-citationSystems Biology, Bioinformatics, and Biomarkers in Neuropsychiatry
Alawieh, A. M., Zaraket, F. A., Li, J., Mondello, S., Nokkari, A., Razafsha, M., Fadlallah, B. H., Boustany, R., & Kobeissy, F. H. (2012) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00187 · Cited by 50
Huynh, T. H. V., Abrahamsen, B., Madsen, K. K., González-Franquesa, A., Jensen, A. A., & Bunch, L. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.09.049 · Cited by 47
Talpos, J. C., Fletcher, A. C., Circelli, C., Tricklebank, M. D., & Dix, S. L. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2590-z · Cited by 47
Wierońska, J. M., Zorn, S. H., Doller, D., & Pilc, A. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.10.007 · Cited by 48
Sugiyama, K., Aida, T., Nomura, M., Takayanagi, R., Zeilhofer, H. U., & Tanaka, K. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.0730-17.2017 · Cited by 43
Self-citationPoletti, S., Riberto, M., Vai, B., Ghiglino, D., Lorenzi, C., Vitali, A., Brioschi, S., Locatelli, C., Serretti, A., Colombo, C., et al. (2018) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1138-7 · Cited by 43
Talpos, J. C., & Steckler, T. (2013) · Cell and Tissue Research · doi:10.1007/s00441-013-1694-7 · Cited by 43
Glutamate transporters: Critical components of glutamatergic transmission
Rodríguez-Campuzano, A. G., & Ortega, A. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108602 · Cited by 44
Consideration of species differences in developing novel molecules as cognition enhancers
Young, J. W., Jentsch, J. D., Bussey, T. J., Wallace, T. L., & Hutcheson, D. M. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.10.002 · Cited by 44
Self-citationLander, S. S., Khan, U., Lewandowski, N. M., Chakraborty, D., Provenzano, F. A., Mingote, S., Chornyy, S., Frigerio, F., Maechler, P., Kaphzan, H., et al. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sby011 · Cited by 38
Behavioral Animal Models of Antipsychotic Drug Actions
Peleg‐Raibstein, D., Feldon, J., & Meyer, U. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25761-2_14 · Cited by 39
Fast Cerebellar Reflex Circuitry Requires Synaptic Vesicle Priming by Munc13-3
Netrakanti, P. R., Cooper, B. H., Dere, E., Poggi, G., Winkler, D., Brose, N., & Ehrenreich, H. (2015) · The Cerebellum · doi:10.1007/s12311-015-0645-0 · Cited by 36
Kirby, B. P., Waddington, J. L., & O’Tuathaigh, C. M. P. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.09.010 · Cited by 36
Ju, P., & Cui, D. (2016) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmv135 · Cited by 33
Exploring Effects of EAAT Polymorphisms on Cognitive Functions in Schizophrenia
Spangaro, M., Bosia, M., Zanoletti, A., Bechi, M., Buonocore, M., Pirovano, A., Lorenzi, C., Bramanti, P., Smeraldi, E., & Cavallaro, R. (2014) · Pharmacogenomics · doi:10.2217/pgs.14.42 · Cited by 33
Yu, H., Patil, K. V., Han, C. J., Fabella, B. A., Canlon, B., Someya, S., & Cederroth, C. R. (2016) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2016.00158 · Cited by 33
Dang, R., Liu, A., Zhou, Y., Li, X., Wu, M., Cao, K., Meng, Y., Zhang, H., Gan, G., Xie, W., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52974-3 · Cited by 33
Boxelaere, M. V., Clements, J., Callaerts, P., D’Hooge, R., & Callaerts‐Vegh, Z. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188537 · Cited by 34
Control of complex behavior by astrocytes and microglia
Ortinski, P. I., Reissner, K. J., Turner, J. R., Anderson, T. L., & Scimemi, A. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104651 · Cited by 32
Huynh, T. H. V., Shim, I., Bohr, H. G., Abrahamsen, B., Nielsen, B., Jensen, A. A., & Bunch, L. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300345z · Cited by 29
Stress-Induced Deficits in Cognition and Emotionality: A Role for Glutamate
Graybeal, C., Kiselycznyk, C., & Holmes, A. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2011_193 · Cited by 30
Self-citationMcCullumsmith, R. E., & Sanacora, G. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.218 · Cited by 28
Yanagisawa, M., Aida, T., Takeda, T., Namekata, K., Harada, T., Shinagawa, R., & Tanaka, K. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.45 · Cited by 28
Self-citationRobson, J. P., Wagner, B., Glitzner, E., Heppner, F. L., Steinkellner, T., Khan, D., Petritsch, C. K., Pollak, D. D., Sitte, H. H., & Sibilia, M. C. (2018) · FEBS Journal · doi:10.1111/febs.14603 · Cited by 25
Schacke, S., Kirkpatrick, J. M., Stocksdale, A., Bauer, R., Hagel, C., Riecken, L. B., & Morrison, H. (2022) · Glia · doi:10.1002/glia.24253 · Cited by 25
Transcriptional Regulation of the GLAST/EAAT-1 Gene in Rat and Man
Unger, T., Lakowa, N., Bette, S. J., & Engele, J. (2012) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9790-2 · Cited by 27
Deciphering the mechanisms of regulation of an excitatory synapse via cyclooxygenase-2. A review
Stachowicz, K. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114729 · Cited by 27
Zhou, Z. C., Yu, C., Sellers, K. K., & Frӧhlich, F. (2016) · Scientific Reports · doi:10.1038/srep23568 · Cited by 27
Overstimulation of NMDA Receptors Impairs Early Brain Development in vivo
Aida, T., Ito, Y., Takahashi, Y. K., & Tanaka, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036853 · Cited by 23
Self-citationCharacterization of a Novel Mutation in SLC1A1 Associated with Schizophrenia
Afshari, P., Myles‐Worsley, M., Cohen, O. S., Tiobech, J., Faraone, S. V., Byerley, W., & Middleton, F. A. (2015) · Complex Psychiatry · doi:10.1159/000433599 · Cited by 23
Mussulini, B. H. M., Vizuete, A. F. K., Braga, M. M., Moro, L., Baggio, S., Santos, E. D. R., Lazzarotto, G., Zenki, K. C., Pettenuzzo, L. F., da Rocha, J. B. T., et al. (2018) · NeuroToxicology · doi:10.1016/j.neuro.2018.04.007 · Cited by 22
Scumpia, P. O., Kelly‐Scumpia, K. M., & Stevens, B. R. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.11.006 · Cited by 24
Carr, G. V., Jenkins, K. A., Weinberger, D. R., & Papaleo, F. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.12.021 · Cited by 22
Dopamine D2L Receptor Is Required for Visual Discrimination and Reversal Learning
Morita, M., Wang, Y., Sasaoka, T., Okada, K., Niwa, M., Sawa, A., & Hikida, T. (2016) · Complex Psychiatry · doi:10.1159/000447970 · Cited by 19
Metadata
- Authors
- Karlsson, R.-M., Tanaka, K., Saksida, L. M., Bussey, T. J., Heilig, M., & Holmes, A.
- Affiliations
- National Institutes of Health (US)
- Tokyo Medical and Dental University (JP)
- University of Cambridge (GB)
- Corresponding author
- Karlsson, Rose-Marie
- Venue
- Neuropsychopharmacology
- Published
- 2008-12-10
- Volume
- 34
- Issue
- 6
- Pages
- 1578-1589
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- PMC
- PMC3400972
- OpenAlex
- W2084421163
- Cited by
- 165
- References
- 66
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 7 · 2023: 4 · 2022: 7 · 2021: 9 · 2020: 6 · 2019: 9 · 2018: 11 · 2017: 5 · 2016: 10 · 2015: 12 · 2014: 11 · 2013: 17 · 2012: 16
- FWCI
- 7.73
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Johns Hopkins University
- Novartis Foundation
- Tokyo Biochemical Research Foundation
- NOVARTIS Foundation (Japan) for the Promotion of Science
- Research Foundation for Opto-Science and Technology
- National Institutes of Health
- Japan Society for the Promotion of Science (20022013, 18053006)
- National Institute on Alcohol Abuse and Alcoholism (ZIAAA000411)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Keywords
- GLAST, glutamate transporters, schizophrenia, negative symptoms, cognitive symptoms, prepulse inhibition, acoustic startle response, social withdrawal, anhedonia, visual discrimination learning, extinction learning, LY379268, haloperidol, knockout mice
- MeSH terms
- Amino Acids, Animals, Cognition, Cognition Disorders, Disease Models, Animal, Female, Food Preferences, Learning, Male, Mice, Inbred C57BL, Mice, Transgenic, Motor Activity, Phenotype, Schizophrenia, Social Behavior Disorders, Reflex, Startle, Sucrose, Receptors, Metabotropic Glutamate, Bridged Bicyclo Compounds, Heterocyclic, Excitatory Amino Acid Transporter 1, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review